Plasma Levels of Antiepileptic Drugs in Children on the Ketogenic Diet

Pediatric Neurology

Volumn 35, Issue 1, 2006, Pages 6-10

  Dahlin, Maria G ^a   Beck, Olof M L ^a   Åmark, Per E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; CALCULATION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; FOOD DRUG INTERACTION; HUMAN; KETOGENIC DIET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KETONES; MALE; PROSPECTIVE STUDIES;

EID: 33745241092     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2005.11.001     Document Type: Article

References (16)

1. Wheless J.W., and Ashwal S. The ketogenic diet. In: Swaiman K.F., and Ashwal S. (Eds). Pediatric neurology. Principles & practice. 3rd ed. (1999), Mosby, St. Louis 719-728
2. Freeman J.M., Kelly M.T., and Freeman J.B. Initiating the ketogenic diet. Fine-tuning the diet. In: Freeman J.M., Kelly M.T., and Freeman J.B. (Eds). The epilepsy diet treatment. 2nd ed. (1996), Demos Publications, New York 65-113
3. Swink T.D., Vining E.P.G., and Freeman J.M. The ketogenic diet. Adv Pediatr 44 (1997) 297-329 Review
4. Kinsman S.L., Vining E.P.G., Quaskey S.A., Mellits D., and Freeman J.M. Efficacy of the ketogenic diet for intractable seizure disorders. Review of 58 cases. Epilepsia 33 (1992) 1132-1136
5. Hassan A.M., Keene D.L., Whiting S.E., Jacob P.J., Champagne J.R., and Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr Neurol 21 (1999) 548-552
6. DiMario F.J., and Holland J. The ketogenic diet. A review of the experience at Connecticut Children′s Medical Center. Pediatr Neurol 26 (2002) 288-292
7. Casey J.C., McGrogan J., Pillas D., Pyzik P., Freeman J., and Vining E.P.G. The implementation and maintenance of the ketogenic diet in children. J Neurosci Nursing 31 (1999) 294-302
8. Tallian K.B., Nahata M.C., and Tsao C. Role of the ketogenic diet in children with intractable seizures. Ann Pharmacother 32 (1998) 349-361
9. Rang H.P., Dale M.M., and Ritter J.M. Absorption and distribution of drugs. In: Rang H.P., Dale M.M., and Ritter J.M. (Eds). Pharmacology (1999), Churchill Livingstone, Edinburgh 61-77
10. Ballaban-Gil K., Callahan C., O′Dell C., Pappo M., Moshe S., and Shinnar S. Complications of the ketogenic diet. Epilepsia 39 (1998) 744-748
11. McNamara J.O. Drugs effective in the therapy of epilepsies. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman′s The pharmacological basis of therapeutics (1996), McGraw-Hill, New York 461-486
12. Fraser D.D., Whiting S., Andrew R.D., Macdonald E.A., Musa-Veloso K., and Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60 (2003) 1026-1029
13. Johannessen C.U., and Johannessen S.I. Valproate. Past, present, and future. CNS Drug Rev 9 (2003) 199-216
14. Bazil C.W., and Pedley T.A. Clinical pharmacology of antiepileptic drugs. Clin Neuropharm 26 (2003) 38-52
15. Rosenfeld W.E., Liao S., Kramer L.D., et al. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 38 (1997) 324-333
16. Gisclon L.G., Curtin C.R., and Kramer L.D. The steady-state (SS) pharmacokinetics (PK) of phenytoin (Dilantin) and topiramate (Topamax™) in epileptic patients on monotherapy, and during combination therapy. Epilepsia 35 Suppl. 8 (1994) 54